I agree that this site is using cookies. You can find further informations here.
X
Whipple, Angela D.
21  results:
Search for persons X
?
1

Development of the California school climate and safety sur..:

Furlong, Michael J. ; Greif, Jennifer L. ; Bates, Michael P....
Psychology in the Schools.  42 (2005)  2 - p. 137-149 , 2005
Link: https://doi.org/10.1002/..
 
?
2

Student Ratings of Stressful Experiences at Home and School..:

Anderson, Gabrielle E. ; Jimerson, Shane R. ; Whipple, Angela D.
Journal of Applied School Psychology.  21 (2005)  1 - p. 1-20 , 2005
Link: https://doi.org/10.1300/..
 
?
3

Winning the battle and losing the war: Examining the relati..:

Jimerson, Shane R. ; Anderson, Gabrielle E. ; Whipple, Angela D.
Psychology in the Schools.  39 (2002)  4 - p. 441-457 , 2002
Link: https://doi.org/10.1002/..
 
?
4

Genotype-Environment Correlations for Language-Related Abil..:

Gilger, Jeffrey W. ; Ho, Hsiu-Zu ; Whipple, Angela D..
Journal of Learning Disabilities.  34 (2001)  6 - p. 492-502 , 2001
Link: https://doi.org/10.1177/..
 
?
5

Evaluation of the Latent Tuberculosis Care Cascade Among Pu..:

Holzman, Samuel B ; Perry, Allison ; Saleeb, Paul...
Clinical Infectious Diseases.  75 (2022)  10 - p. 1792-1799 , 2022
Link: https://doi.org/10.1093/..
 
?
6

CTNI-68. FIREFLY-1 (PNOC026): PHASE 2 STUDY OF PAN-RAF INHI..:

Kilburn, Lindsay ; Landi, Daniel ; Leary, Sarah...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii89-vii89 , 2022
Link: https://doi.org/10.1093/..
 
?
7

Contributor Biographical Sketches:

, In: The Experiential Library,
Anderson, Christopher J. ; Balius, Angela H. ; Barlow, Amy... - p. xiii-xxiii , 2017
Link: https://doi.org/10.1016/..
 
?
8

Potency enhancement of the κ-opioid receptor antagonist pro..:

Frankowski, Kevin J. ; Slauson, Stephen R. ; Lovell, Kimberly M....
Bioorganic & Medicinal Chemistry.  23 (2015)  14 - p. 3948-3956 , 2015
Link: https://doi.org/10.1016/..
 
?
9

TRLS-03. A PHASE 1/2 STUDY ASSESSING SAFETY AND PHARMACOKIN..:

Kline, Cassie ; Schoenfeld, Jonathan D ; Gajjar, Amar...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
10

HGG-32. PNOC008: A PILOT TRIAL TESTING THE CLINICAL BENEFIT..:

Franson, Andrea T ; Kilburn, Lindsay B ; Cooney, Tab M...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
11

Author Correction: The type II RAF inhibitor tovorafenib in..:

Kilburn, Lindsay B. ; Khuong-Quang, Dong-Anh ; Hansford, Jordan R....
Nature Medicine.  30 (2024)  5 - p. 1500-1500 , 2024
Link: https://doi.org/10.1038/..
 
?
12

LGG-40. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRA..:

Kline, Cassie ; Waanders, Angela J ; Ziegler, David S...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
13

Study Design, Rationale, and Methodology for Promote Weight..:

Whipple, Mary O. ; Pfammatter, Angela Fidler ; Spring, Bonnie...
Journal of the American Heart Association.  12 (2023)  17 - p. , 2023
Link: https://doi.org/10.1161/..
 
?
14

The type II RAF inhibitor tovorafenib in relapsed/refractor..:

Kilburn, Lindsay B. ; Khuong-Quang, Dong-Anh ; Hansford, Jordan R....
Nature Medicine.  30 (2023)  1 - p. 207-217 , 2023
Link: https://doi.org/10.1038/..
 
?
15

Different factors limit early- and late-season windows of o..:

Yang, Louie ; Swan, Karen ; Bastin, Eric...
https://zenodo.org/communities/dryad.  , 2022
Link: https://zenodo.org/recor..
 
1-15